CDKN2A and small cell lung carcinoma: While there was no significant link between CDKN2A and disease-free survival, the overall survival of SCLC patients with high CDKN2A expression was considerably worse than that of patients with low CDKN2A expression, suggesting that CDKN2A may be a key prognostic indicator for SCLC patients.